RECRUITINGOBSERVATIONAL
The National Amyotrophic Lateral Sclerosis Registry
About This Trial
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.
Who May Be Eligible (Plain English)
Who May Qualify:
\- U.S. citizens 18 years of age or older
Who Should NOT Join This Trial:
\-
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
\- U.S. citizens 18 years of age or older
Exclusion Criteria:
\-
Locations (1)
CDC
Atlanta, Georgia, United States